Entrada Therapeutics, Inc. (TRDA)

Entrada Therapeutics Market Cap

Entrada Therapeutics has a market cap or net worth of $506.38 million as of May 17, 2024. Its market cap has increased by 25.56% in one year.

• Market Cap: 506.38M
• Enterprise Value: 241.45M
• 1-Year Change: 25.56%
• Ranking: #2981
• Category: Small-Cap
• Stock Price: $14.99

Market Cap Chart

Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has decreased from $597.75M to $506.38M, a decrease of -15.28%. That is a compound annual growth rate of -6.30%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	506.00M	0.26%
May 16, 2024	504.70M	3.17%
May 15, 2024	489.20M	2.13%
May 14, 2024	479.00M	0.99%
May 13, 2024	474.30M	-2.02%
May 10, 2024	484.10M	-0.14%
May 9, 2024	484.80M	2.21%
May 8, 2024	474.30M	1.22%
May 7, 2024	468.60M	3.31%
May 6, 2024	453.60M	2.58%
May 3, 2024	442.20M	-2.94%
May 2, 2024	455.60M	2.34%
May 1, 2024	445.20M	11.80%
Apr 30, 2024	398.20M	-3.96%
Apr 29, 2024	414.60M	-0.88%
Apr 26, 2024	418.30M	0.72%
Apr 25, 2024	415.30M	-0.57%
Apr 24, 2024	417.70M	-3.56%
Apr 23, 2024	433.10M	-1.61%
Apr 22, 2024	440.20M	7.81%
Apr 19, 2024	408.30M	2.02%
Apr 18, 2024	400.20M	-2.53%
Apr 17, 2024	410.60M	-3.93%
Apr 16, 2024	427.40M	-1.32%
Apr 15, 2024	433.10M	-0.46%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
Larimar Therapeutics	502.11M
MaxCyte	498.67M
UroGen Pharma	497.87M
Editas Medicine	493.43M
Verve Therapeutics	489.36M
Talkspace	488.69M
Nkarta	484.82M
Fate Therapeutics	482.65M